News
ICLR
151.82
-0.28%
-0.42
Is ICON (ICLR) Using Buybacks And New Directors To Reset Trust After Control Weaknesses?
Simply Wall St · 5h ago
ICON plc options imply 3.1% move in share price post-earnings
TipRanks · 1d ago
ICON Stock Valuation vs Peers: Is ICLR Cheap Enough?
NASDAQ · 1d ago
Weekly Report: what happened at ICLR last week (0601-0605)?
Weekly Report · 1d ago
ICLR Earnings Reset: What the Accounting Probe Changed
NASDAQ · 4d ago
ICON files Form 3 for new director Kevin Francis Egan
PUBT · 4d ago
ICON files Form 3 initial beneficial ownership statement for new director Jeffrey Thomas Elliott
PUBT · 4d ago
SUNFLOWER Lupus Trial Puts AstraZeneca and ICON in Focus for Long‑Term Investors
TipRanks · 06/02 16:31
ICON's Clinical Trial Backlog Keeps Growing but Revenue per Study Tells a Different Story
Barchart · 06/02 16:01
Analyst Maintains Buy on ICON as Accounting Overhang Clears and Long‑Term Earnings Growth Outlook Remains Intact
TipRanks · 06/02 11:52
ICON (ICLR) Valuation Check After Recent Share Price Rebound
Simply Wall St · 06/02 11:24
Icon Is Maintained at Buy by TD Cowen
Dow Jones · 06/01 15:12
TD Cowen Maintains Buy on Icon, Raises Price Target to $164
Benzinga · 06/01 15:04
Icon price target raised to $164 from $120 at TD Cowen
TipRanks · 06/01 13:14
Dell Technologies To Gain Nearly 79%? Here Are 10 Analyst Calls Investors Should Know
Benzinga · 06/01 12:43
Icon Price Target Raised to $125.00/Share From $105.00 by B of A Securities
Dow Jones · 06/01 11:07
Icon Is Maintained at Underperform by B of A Securities
Dow Jones · 06/01 11:07
B of A Securities Maintains Underperform on Icon, Raises Price Target to $125
Benzinga · 06/01 10:57
Icon price target raised to $125 from $105 at BofA
TipRanks · 06/01 10:47
Weekly Report: what happened at ICLR last week (0525-0529)?
Weekly Report · 06/01 09:08
More
Webull provides a variety of real-time ICLR stock news. You can receive the latest news about ICON plc through multiple platforms. This information may help you make smarter investment decisions.
About ICLR
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.